Febrile neutropenia and role of prophylactic granulocyte colony-stimulating factor in docetaxel and cyclophosphamide chemotherapy for breast cancer

被引：0
|
作者：
Yuri Kimura
Shinsuke Sasada
Akiko Emi
Norio Masumoto
Takayuki Kadoya
Morihito Okada
机构：
[1] Hiroshima University,Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine
来源：
Supportive Care in Cancer | 2021年 / 29卷
关键词：
Breast cancer; Primary prophylactic G-CSF; Febrile neutropenia; TC chemotherapy; Relative dose intensity; Hospitalization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3507 / 3512
页数：5
相关论文
共 50 条
  • [41] The efficiency of granulocyte colony-stimulating factor in hemorrhagic mucositis and febrile neutropenia resulted from methotrexate toxicity
    Ozkol, Hatice Uce
    Toptas, Tayfur
    Calka, Omer
    Akdeniz, Necmettin
    CUTANEOUS AND OCULAR TOXICOLOGY, 2015, 34 (02) : 173 - 175
  • [42] Granulocyte colony-stimulating factors in the prevention of febrile neutropenia: review of cost-effectiveness models
    Fust, Kelly
    Parthan, Anju
    Maschio, Michael
    Gu, Qing
    Li, Xiaoyan
    Lyman, Gary H.
    Tzivelekis, Spiros
    Villa, Guillermo
    Weinstein, Milton C.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (01) : 39 - 52
  • [43] Patterns of granulocyte colony-stimulating factor prophylaxis in patients with cancer receiving myelosuppressive chemotherapy
    Gawade, Prasad L.
    Li, Shuling
    Henry, David
    Smith, Nancy
    Belani, Rajesh
    Kelsh, Michael A.
    Bradbury, Brian D.
    SUPPORTIVE CARE IN CANCER, 2020, 28 (09) : 4413 - 4424
  • [44] Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer: a systematic review
    Fernandes, Ricardo
    Mazzarello, Sasha
    Stober, Carol
    Vandermeer, Lisa
    Dudani, Shaan
    Ibrahim, Mohamed F. K.
    Majeed, Habeeb
    Perdrizet, Kirstin
    Shorr, Risa
    Hutton, Brian
    Fergusson, Dean
    Clemons, Mark
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (01) : 1 - 10
  • [45] Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis
    Katy L Cooper
    Jason Madan
    Sophie Whyte
    Matt D Stevenson
    Ron L Akehurst
    BMC Cancer, 11
  • [46] Suboptimal Duration of Granulocyte Colony stimulating Factor Use and Chemotherapy-induced Neutropenia in Women Diagnosed With Breast Cancer
    Lin, Wan-Ting
    Wen, Yu-Wen
    Chien, Chun-Ru
    Gau, Churn-Shiouh
    Chiang, Shao C.
    Hsiao, Fei-Yuan
    CLINICAL THERAPEUTICS, 2014, 36 (09) : 1287 - 1294
  • [47] The Role of Colony-Stimulating Factors and Granulocyte Transfusion in Treatment Options for Neutropenia in Children with Cancer
    Der-Cherng Liang
    Pediatric Drugs, 2003, 5 (10) : 673 - 684
  • [48] A retrospective analysis of nadir-neutropenia directed pegylated granulocyte-colony stimulating factor on febrile neutropenia rates in (neo)adjuvant breast cancer chemotherapy regimens
    Zardawi, Sarah J.
    Nordman, Ina
    Zdenkowski, Nicholas
    CANCER REPORTS, 2020, 3 (05)
  • [49] Attitudes of physicians toward assessing risk and using granulocyte colony-stimulating factor as primary prophylaxis in patients receiving chemotherapy associated with an intermediate risk of febrile neutropenia
    Freyer, Gilles
    Kalinka-Warzocha, Ewa
    Syrigos, Konstantinos
    Marinca, Mihai
    Tonini, Giuseppe
    Ng, Say Liang
    Wong, Zee Wan
    Salar, Antonio
    Steger, Guenther
    Abdelsalam, Mahmoud
    DeCosta, Lucy
    Szabo, Zsolt
    MEDICAL ONCOLOGY, 2015, 32 (10)
  • [50] Effect of Primary Prophylactic Granulocyte-Colony Stimulating Factor Use on Incidence of Neutropenia Hospitalizations for Elderly Early-stage Breast Cancer Patients Receiving Chemotherapy
    Rajan, Suja S.
    Lyman, Gary H.
    Stearns, Sally C.
    Carpenter, William R.
    MEDICAL CARE, 2011, 49 (07) : 649 - 657
12345